Skip to content

Electro-acupuncture plus warm needling therapy for heel pain

Electro-acupuncture plus warm needling therapy for heel pain: a randomized controlled tria

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014906
Enrollment
Unknown
Registered
2018-02-12
Start date
2018-03-19
Completion date
Unknown
Last updated
2018-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heel pain

Interventions

Two groups:Electro-acupuncture and warm needling therapy (acupuncture and moxibustion) used in this study are based on traditional Chinese medicine theory and review of literature, for four weeks, Six

Sponsors

Pok Oi Hospital - The Chinese University of Hong Kong Chinese Medicine Centre for Training and Research (Shatin)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. males and females aged 50 to 80 years; 2. heel pain characterized by the pain worsened when standing or walking after getting up in the morning. The pain gets relieved after a while of walking, and worsened after a long period of walking; 3. heel pain with marked tenderness at the plantar aspect and lateral aspect of the calcaneal tuberosity; 4. either unilateral or bilateral heel pain; 5. acute or chronic pain in nature with degree of heel pain experienced upon taking the first few steps rating 50 mm or more on a 0-100 mm visual analogue scale at the time of recruitment; and 6. agreed to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. suffering from pain in another area that is severe than heel pain; 2. loss of plantar foot sensation; 3. open wounds or tumors, skin ulceration on the painful heel(s) and surrounding area; 4. documentation of fracture or abnormalities at the painful heel(s) within 4 weeks that are not suitable for the study treatments; 5. acupuncture and/ or moxibustion treatment for the same heel pain during the previous month; 6. expected ongoing co-interventions (medication or alternative treatments, or both) during study period; 7. previous surgery to the painful heel(s) or scheduled to have one during the study period; 8. severe needle phobia; 9. known hypersensitive reaction after acupuncture and moxibustion treatment or an inability to cooperate with the acupuncture and moxibustion procedure; 10. diagnosis of cancer of any nature within 5 years; 11. known severe disease of the heart, brain, lung, liver, kidney, or hematopoietic system; 12. currently on cardiac pacemaker; 13. pregnant, breast feeding or expecting a pregnancy during the study period; 14. known severe psychiatric or psychological disorder; 15. other factors that have been deemed unsuitable for participation assessed by investigators; 16. engage in any other clinical trial during the study period; 17. pending foot-related litigation or disability claims; and 18. incapable to understand and answer the questions of the assessors in the study.

Design outcomes

Primary

MeasureTime frame
First step pain VAS;

Secondary

MeasureTime frame
Foot Function Index;Global rating of change (GRC) scale;

Countries

China

Contacts

Public ContactLIN Zhixiu

Hong Kong Institute of Integrative Medicine

linzx@cuhk.edu.hk+852 28733252

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 2, 2026